Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors or Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01962532
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma

Who this might be right for
NeoplasmsLymphomaAdenocarcinoma+1 more
Janssen Research & Development, LLC 19
Early research (Phase 1)Study completedNCT00049712
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Ended earlyNCT03013491
What this trial is testing

PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

Who this might be right for
Solid TumorLymphoma
CytomX Therapeutics 196
Early research (Phase 1)Study completedNCT00536835
What this trial is testing

Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 41
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Early research (Phase 1)Study completedNCT01714947
What this trial is testing

Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib

Who this might be right for
Advanced Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 3
Early research (Phase 1)Ended earlyNCT00023166
What this trial is testing

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

Who this might be right for
NeoplasmLymphomasNeoplasm Metastasis
Enzon Pharmaceuticals, Inc.
Early research (Phase 1)Active Not RecruitingNCT05460767
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid Tumors or Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 504
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Study completedNCT01953783
What this trial is testing

Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB

Who this might be right for
Advanced Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 7
Early research (Phase 1)Ended earlyNCT02414724
What this trial is testing

Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Neoplasm
Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Ended earlyNCT01163071
What this trial is testing

Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid Tumors
Celgene 60
Early research (Phase 1)Study completedNCT00412997
What this trial is testing

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Who this might be right for
TumorsCutaneous T-Cell Lymphoma
Novartis 14
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Early research (Phase 1)Study completedNCT00345189
What this trial is testing

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

Who this might be right for
TumorsLymphoma
Biogen 70
Testing effectiveness (Phase 2)Looking for participantsNCT07222631
What this trial is testing

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

Who this might be right for
Non Hodgkin LymphomaSolid Tumor
University of California, San Diego 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994
What this trial is testing

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT04306224
What this trial is testing

IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas

Who this might be right for
Solid TumorLymphoma
ImmuneOncia Therapeutics Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06292208
What this trial is testing

A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors

Who this might be right for
MTD
SUNHO（China）BioPharmaceutical CO., Ltd. 48
Next Page